Search

George A Calin

from Pearland, TX
Age ~56
Get Report
Also known as:
George G Calin, Steliana Calin, Calin George
Phone and address:
12210 Willow Brook Ln, Pearland, TX 77584
(713) 340-0393
Related to:
Horatiu N Calin, 28Steliana Calin, 61
Connected to:
Alexandru Calin, 38Carlos J Calin, 68Cristian M Calin, 42Grant C Calin, 83Gemma N Calinda, 48Toni Calinda, 45Ana M Calingasan, 66Andy T Calingay, 34Carlo D Calingasan, 52Charles L Caling, 78

George Calin Phones & Addresses

  • 12210 Willow Brook Ln, Pearland, TX 77584 (713) 340-0393
  • 7530 Brompton St, Houston, TX 77025 (713) 592-9472
  • 2428 Sawmill Village Dr, Columbus, OH 43235 (614) 760-5856
  • 7373 Ridge Ave, Philadelphia, PA 19128 (215) 508-1975
  • 12210 Willow Brook Ln, Pearland, TX 77584

Work

Position: Homemaker

Resumes

Resumes

George Calin Photo 1

Information Architect At Lacon Electronic Gmbh

View page
Position:
Information Architect at Lacon Electronic
Location:
Galati County, Romania
Industry:
Maritime
Work:
Lacon Electronic since May 2012
Information Architect
Lacon Electronic Jun 2008 - Apr 2012
Logistics Manager
Lacon Electronic Jan 2008 - Jun 2008
Manufacturing planning and scheduling coordinator
D&D Cosmetics Jul 2007 - Dec 2007
Marketing Manager
A.P. Moller - Maersk Group Jun 2006 - Mar 2007
Officer of the Watch
Education:
Universitatea „Dunărea de Jos” din Galați 2007 - 2008
Master's degree, Accounting Information Systems Universitatea „Dunărea de Jos” din Galați 2001 - 2005
BA Econ, Accounting and Computing Universitatea Maritimă din Constanța 1997 - 2002
BEng+Maritime Deck Officer, Navigation and Maritime Transport
George Calin Photo 2

Composer - Pianist At Free-Lancer

View page
Position:
Composer - pianist at Free-lancer
Location:
Constantza County, Romania
Industry:
Music
Work:
Free-lancer
Composer - pianist
Sud-Est Production Nov 1999 - Dec 2006
G.Calin
Sud-Est Production Nov 1999 - Dec 2006
Composer -orchestrator
George Calin Photo 3

Professor

View page
Location:
Houston, TX
Industry:
Hospital & Health Care
Work:
Md Anderson Cancer Center
Professor
Skills:
Molecular Biology
Cancer
Cell Biology
Cancer Research
Genetics
Translational Research
Life Sciences
Cell Culture
Biochemistry
Clinical Research
Western Blotting
Oncology
Pcr
Genomics
Immunology
Science
Immunohistochemistry
Cell
Animal Models
Lifesciences
Flow Cytometry
Biotechnology
Medicine
Bioinformatics
Breast Cancer
Medical Education
Rna
Transfection
George Calin Photo 4

Researcher

View page
Location:
12210 Willow Brook Ln, Pearland, TX 77584
Industry:
Hospital & Health Care
Work:
MDACC
researcher
George Calin Photo 5

Electrician At Capital Ship Management Corp.

View page
Position:
electrician at CAPITAL SHIP MANAGEMENT CORP.
Location:
Constantza County, Romania
Industry:
Maritime
Work:
CAPITAL SHIP MANAGEMENT CORP. since Aug 2010
electrician
Education:
IMAT 2008 - 2011
licenced

Publications

Us Patents

Diagnosis And Treatment Of Cancers With Microrna Located In Or Near Cancer Associated Chromosomal Features

View page
US Patent:
7723030, May 25, 2010
Filed:
Jul 29, 2005
Appl. No.:
11/194055
Inventors:
Carlo M. Croce - Columbus OH, US
Chang-Gong Liu - Powell OH, US
George A. Calin - Columbus OH, US
Cinzia Sevignani - Philadelphia PA, US
Assignee:
Thomas Jefferson University - Philadelphia PA
International Classification:
C12Q 1/68
US Classification:
435 6
Abstract:
MicroRNA genes are highly associated with chromosomal features involved in the etiology of different cancers. The perturbations in the genomic structure or chromosomal architecture of a cell caused by these cancer-associated chromosomal features can affect the expression of the miR gene(s) located in close proximity to that chromosomal feature. Evaluation of miR gene expression can therefore be used to indicate the presence of a cancer-causing chromosomal lesion in a subject. As the change in miR gene expression level caused by a cancer-associated chromosomal feature may also contribute to cancerigenesis, a given cancer can be treated by restoring the level of miR gene expression to normal. microRNA expression profiling can be used to diagnose cancer and predict whether a particular cancer is associated with an adverse prognosis. The identification of specific mutations associated with genomic regions that harbor miR genes in CLL patients provides a means for diagnosing CLL and possibly other cancers.

Compositions And Methods For Cancer Diagnosis And Therapy

View page
US Patent:
7723035, May 25, 2010
Filed:
Mar 13, 2006
Appl. No.:
11/375650
Inventors:
Carlo Croce - Philadelphia PA, US
George Calin - Philadelphia PA, US
Assignee:
Thomas Jefferson University - Philadelphia PA
International Classification:
C12Q 1/68
C07H 21/04
A61K 31/70
US Classification:
435 6, 536 241
Abstract:
The miR15 and miR16 micro RNA genes are located at 13q14 within a 30 kb region of loss characteristic of cells from certain cancers, such as cells from chronic lymphocytic leukemia or prostate cancer. Chronic lymphocytic leukemia or prostate cancer can be diagnosed by detecting a reduction in miR15 or miR16 gene copy number, by determining miR15 or miR16 gene mutational status, or by detecting a reduction in the RNA transcribed from these genes. The miR15 or miR16 gene products can inhibit the neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells when administered to subjects suffering from these diseases.

Microrna Fingerprints During Human Megakaryocytopoiesis

View page
US Patent:
7985584, Jul 26, 2011
Filed:
Mar 19, 2007
Appl. No.:
12/293471
Inventors:
Carlo M. Croce - Columbus OH, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Assignee:
The Ohio State University Research Foundation - Columbus OH
International Classification:
C12Q 1/68
US Classification:
435325, 435 6, 435375, 536 245, 536 2431, 536 241
Abstract:
The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of cancer and myeloproliferative disorders. The invention also provides methods of identifying anti-cancer agents.

Microrna-Based Methods And Compositions For The Diagnosis, Prognosis And Treatment Of Solid Cancers

View page
US Patent:
8148069, Apr 3, 2012
Filed:
Jan 3, 2007
Appl. No.:
12/160061
Inventors:
Carlo M. Croce - Columbus OH, US
George A. Calin - Pearland TX, US
Stefano Volinia - Ferrara, IT
Assignee:
The Ohio State University - Columbus OH
International Classification:
C12Q 1/68
US Classification:
435 61
Abstract:
The present invention provides novel methods and compositions for the diagnosis and treatment of solid cancers. The invention also provide methods of identifying inhibitors of tumorigenesis.

Microrna Fingerprints During Human Megakaryocytopoiesis

View page
US Patent:
8354224, Jan 15, 2013
Filed:
Jun 27, 2011
Appl. No.:
13/169184
Inventors:
Carlo M. Croce - Columbus OH, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Assignee:
The Ohio State University - Columbus OH
International Classification:
C12Q 1/68
US Classification:
435 6, 435325, 435375
Abstract:
The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of cancer and myeloproliferative disorders. The invention also provides methods of identifying anti-cancer agents.

Microrna Expression Abnormalities In Pancreatic Endocrine And Acinar Tumors

View page
US Patent:
8389210, Mar 5, 2013
Filed:
Feb 4, 2010
Appl. No.:
12/700286
Inventors:
Carlo M. Croce - Columbus OH, US
George A. Calin - Pearland TX, US
Assignee:
The Ohio State University Research Foundation - Columbus OH
International Classification:
C12Q 1/68
C12P 19/34
C07H 21/02
C07H 21/04
US Classification:
435 6, 435 911, 435 9131, 536 231, 536 2431, 536 245
Abstract:
The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of pancreatic cancer. The invention also provides methods of identifying anti-pancreatic cancer agent.

Compositions And Methods For The Diagnosis And Therapy Of Bcl2-Associated Cancers

View page
US Patent:
8481505, Jul 9, 2013
Filed:
Sep 11, 2006
Appl. No.:
11/991773
Inventors:
Carlo M. Croce - Columbus OH, US
George A. Calin - Columbus OH, US
Assignee:
The Ohio State University Research Foundation - Columbus OH
International Classification:
C12N 15/11
C61K 48/00
C07H 21/02
C07H 21/04
US Classification:
514 44A, 536 245
Abstract:
The invention provides methods and compositions for the treatment of cancers associated with overexpression of a BCL2 gene and/or gene product in a subject, and methods and compositions for the improvement of anti-cancer therapy, such as chemotherapy and radiation therapy. The invention also encompasses methods for determining the efficacy of a cancer therapy in a subject and methods for inducing apoptosis of a cell.

Microrna Fingerprints During Human Megakaryocytopoiesis

View page
US Patent:
8486912, Jul 16, 2013
Filed:
Aug 27, 2012
Appl. No.:
13/595200
Inventors:
Carlo M. Croce - Columbus OH, US
Ramiro Garzon - Columbus OH, US
George A. Calin - Pearland TX, US
Assignee:
The Ohio State University Research Foundation - Columbus OH
International Classification:
A61K 48/00
US Classification:
514 44, 536 245, 536 2431, 536 241
Abstract:
Described herein is a method of decreasing expression of MAFB in a subject having a cancer and/or myeloproliferative disorder associated with overexpression of a MAFB gene product where an effective amount of at least one miR-130a gene product or an isolated variant or biologically-active fragment thereof is administered to the subject sufficient to decrease expression of the MAFB gene product in the subject.
Control profile
George A Calin from Pearland, TX, age ~56 Get Report